ITHACA, N.Y.--(BUSINESS WIRE)--April 5, 2006--Protein developer Viral Therapeutics, Inc., known for its innovations in protein technology, has changed its name to Vybion (VY-bee-yon), Inc. The company's strength in biopharmaceutical development is its proprietary Protein Evolution Tools, more than a decade of experience and successful track record. Its Protein Evolution Tools, applied to both internal and external projects, dramatically reduce time-to-market, increase production yield and bioactivity. Vybion's drug pipeline currently includes a drug that is effective against all strains of influenza and is expected to enter clinical trials before the end of 2006.
